 | • レポートコード：MRC2301B049 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、225ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：食品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社発行の当調査レポートでは、2021年に4,982.11百万ドルであった世界ののど飴（トローチ）市場規模が、2022年に5,324.39百万ドルに達し、2027年には7,529.35百万ドルまで年平均7.12%で成長すると予測しています。当レポートは、のど飴（トローチ）の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、成分別（メントール系のど飴、非メンソール系のど飴）分析、種類別（トローチ、ハードキャンディートローチ、ソフトトローチ）分析、使用別（抗菌トローチ、医薬品トローチ）分析、用途別（咳＆風邪、のどの疾患、のどの痛み）分析、流通チャネル別（病院薬局、オンライン薬局、小売薬局）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめております。なお、当書には、Bausch Health Companies Inc.、Catalent, Inc.、Dabur Ltd.、Doetsch Grether AG、Ernest Jackson＆Co. Ltd.、Gepach International、GSK plc、Honibe、J B Chemicals and Pharmaceuticals Ltd.、Mondelēz International, Inc.、Pfizer Inc.、Piramal Group、Prestige Consumer Healthcare, Inc.、Procter＆Gamble Companyなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界ののど飴（トローチ）市場規模：成分別 - メントール系のど飴の市場規模 - 非メンソール系のど飴の市場規模 ・世界ののど飴（トローチ）市場規模：種類別 - トローチの市場規模 - ハードキャンディートローチの市場規模 - ソフトトローチの市場規模 ・世界ののど飴（トローチ）市場規模：使用別 - 抗菌トローチの市場規模 - 医薬品トローチの市場規模 ・世界ののど飴（トローチ）市場規模：用途別 - 咳＆風邪における市場規模 - のどの疾患における市場規模 - のどの痛みにおける市場規模 ・世界ののど飴（トローチ）市場規模：地域別 - 南北アメリカののど飴（トローチ）市場規模 アメリカののど飴（トローチ）市場規模 カナダののど飴（トローチ）市場規模 ブラジルののど飴（トローチ）市場規模 ... - アジア太平洋ののど飴（トローチ）市場規模 日本ののど飴（トローチ）市場規模 中国ののど飴（トローチ）市場規模 インドののど飴（トローチ）市場規模 韓国ののど飴（トローチ）市場規模 台湾ののど飴（トローチ）市場規模 ... - ヨーロッパ/中東/アフリカののど飴（トローチ）市場規模 イギリスののど飴（トローチ）市場規模 ドイツののど飴（トローチ）市場規模 インドののど飴（トローチ）市場規模 フランスののど飴（トローチ）市場規模 ロシアののど飴（トローチ）市場規模 ... - その他地域ののど飴（トローチ）市場規模 ・競争状況 ・企業情報 |
The Global Throat Lozenges Market size was estimated at USD 4,982.11 million in 2021 and expected to reach USD 5,324.39 million in 2022, and is projected to grow at a CAGR 7.12% to reach USD 7,529.35 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Throat Lozenges to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Ingredient Type, the market was studied across Menthol Throat Lozenges and Non-menthol Throat Lozenges.
Based on Type, the market was studied across Compressed Lozenges, Hard Candy Lozenges, and Soft Lozenges.
Based on Usage, the market was studied across Antibacterial Lozenges and Pharmaceutical Lozenges.
Based on Application, the market was studied across Cough & Cold, Throat Diseases, and Throat Soreness.
Based on Distribution Channel, the market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Throat Lozenges market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Throat Lozenges Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Throat Lozenges Market, including Bausch Health Companies Inc., Catalent, Inc., Dabur Ltd., Doetsch Grether AG, Ernest Jackson & Co. Ltd., Gepach International, GSK plc, Honibe, J B Chemicals and Pharmaceuticals Ltd., Mondelēz International, Inc., Pfizer Inc., Piramal Group, Prestige Consumer Healthcare, Inc., Procter & Gamble Company, Reckitt Benckiser Group plc, Ricola AG, Sanofi S.A., SSL International plc, TerrAscend, Thornton & Ross, Traditional Medicinals, Inc., and Wrigley Company.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Throat Lozenges Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Throat Lozenges Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Throat Lozenges Market?
4. What is the competitive strategic window for opportunities in the Global Throat Lozenges Market?
5. What are the technology trends and regulatory frameworks in the Global Throat Lozenges Market?
6. What is the market share of the leading vendors in the Global Throat Lozenges Market?
7. What modes and strategic moves are considered suitable for entering the Global Throat Lozenges Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of sore throat and throat infections
5.1.1.2. Emergence of numerous infectious diseases across the globe
5.1.1.3. Rising consumer awareness toward oral care and hygiene
5.1.2. Restraints
5.1.2.1. Short-term health impact of using throat lozenges
5.1.3. Opportunities
5.1.3.1. Development of advanced product portfolios with novel formulations
5.1.3.2. Growing consumer preference for online pharmaceutical channels
5.1.4. Challenges
5.1.4.1. Presence of numerous low-cost alternatives
5.2. Cumulative Impact of COVID-19
6. Throat Lozenges Market, by Ingredient Type
6.1. Introduction
6.2. Menthol Throat Lozenges
6.3. Non-menthol Throat Lozenges
7. Throat Lozenges Market, by Type
7.1. Introduction
7.2. Compressed Lozenges
7.3. Hard Candy Lozenges
7.4. Soft Lozenges
8. Throat Lozenges Market, by Usage
8.1. Introduction
8.2. Antibacterial Lozenges
8.3. Pharmaceutical Lozenges
9. Throat Lozenges Market, by Application
9.1. Introduction
9.2. Cough & Cold
9.3. Throat Diseases
9.4. Throat Soreness
10. Throat Lozenges Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Americas Throat Lozenges Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Throat Lozenges Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Throat Lozenges Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Bausch Health Companies Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Catalent, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Dabur Ltd.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Doetsch Grether AG
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Ernest Jackson & Co. Ltd.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Gepach International
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. GSK plc
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Honibe
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. J B Chemicals and Pharmaceuticals Ltd.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Mondelēz International, Inc.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Pfizer Inc.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Piramal Group
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Prestige Consumer Healthcare, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Procter & Gamble Company
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Reckitt Benckiser Group plc
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Ricola AG
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Sanofi S.A.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. SSL International plc
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. TerrAscend
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Thornton & Ross
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Traditional Medicinals, Inc.
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
15.22. Wrigley Company
15.22.1. Business Overview
15.22.2. Key Executives
15.22.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing